GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations

British Journal of Haematology

Volumn 161, Issue 5, 2013, Pages 701-705

  Green, Claire L ^a   Tawana, Kiran ^b   Hills, Robert K ^c   Bödör, Csaba ^b   Fitzgibbon, Jude ^b   Inglott, Sarah ^d   Ancliff, Phil ^d   Burnett, Alan K ^c   Linch, David C ^a   Gale, Rosemary E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Acute myeloid leukaemia; CEBPA; Familial AML; GATA2; Prognostic factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; TRANSCRIPTION FACTOR GATA 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER SURVIVAL; CCAAT ENHANCER BINDING PROTEIN ALPHA GENE; CONTROLLED STUDY; FAMILIAL CANCER; GENE DUPLICATION; GERM LINE; HETEROZYGOSITY; HUMAN; KARYOTYPE; LEUKEMIA REMISSION; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PEDIGREE ANALYSIS; PRIORITY JOURNAL; TRANSCRIPTION FACTOR GATA 2 GENE; TUMOR GENE; WILD TYPE;

ADOLESCENT; ADULT; AGED; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; GATA2 TRANSCRIPTION FACTOR; GERM-LINE MUTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PEDIGREE; PROGNOSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877817046     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12317     Document Type: Article

References (12)

1. Dufour, A., Schneider, F., Metzeler, K.H., Hoster, E., Schneider, S., Zellmeier, E., Benthaus, T., Sauerland, M.C., Berdel, W.E., Buchner, T., Wormann, B., Braess, J., Hiddemann, W., Bohlander, S.K. & Spiekermann, K. (2010) Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. Journal of Clinical Oncology, 28, 570-577.
2. Fasan, A., Eder, C., Haferlach, C., Grossmann, V., Kohlmann, A., Dicker, F., Kern, W., Haferlach, T. & Schnittger, S. (2013) GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis. Leukemia, 27, 482-485.
3. Gale, R.E., Green, C., Allen, C., Mead, A.J., Burnett, A.K., Hills, R.K. & Linch, D.C. (2008) The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia. Blood, 111, 2776-2784.
4. Green, C.L., Koo, K.K., Hills, R.K., Burnett, A.K., Linch, D.C. & Gale, R.E. (2010) Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. Journal of Clinical Oncology, 28, 2739-2747.
5. Greif, P.A., Dufour, A., Konstandin, N.P., Ksienzyk, B., Zellmeier, E., Tizazu, B., Sturm, J., Benthaus, T., Herold, T., Yaghmaie, M., Dorge, P., Hopfner, K.P., Hauser, A., Graf, A., Krebs, S., Blum, H., Kakadia, P.M., Schneider, S., Hoster, E., Schneider, F., Stanulla, M., Braess, J., Sauerland, M.C., Berdel, W.E., Buchner, T., Woermann, B.J., Hiddemann, W., Spiekermann, K. & Bohlander, S.K. (2012) GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood, 120, 395-403.
6. Hahn, C.N., Chong, C.E., Carmichael, C.L., Wilkins, E.J., Brautigan, P.J., Li, X.C., Babic, M., Lin, M., Carmagnac, A., Lee, Y.K., Kok, C.H., Gagliardi, L., Friend, K.L., Ekert, P.G., Butcher, C.M., Brown, A.L., Lewis, I.D., To, L.B., Timms, A.E., Storek, J., Moore, S., Altree, M., Escher, R., Bardy, P.G., Suthers, G.K., D'Andrea, R.J., Horwitz, M.S. & Scott, H.S. (2011) Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nature Genetics, 43, 1012-1017.
7. Luesink, M., Hollink, H., van der Velden, V.H., Knops, R.H., Boezeman, J.B., de Haas, V., Trka, J., Baruchel, A., Reinhardt, D., van der Reijden, B.A., van den Heuvel-Eibrink, M.M., Zwaan, C.M. & Jansen, J.H. (2012) High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. Blood, 120, 2064-2075.
8. Renneville, A., Mialou, V., Philippe, N., Kagialis-Girard, S., Biggio, V., Zabot, M.T., Thomas, X., Bertrand, Y. & Preudhomme, C. (2009) Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation. Leukemia, 23, 804-806.
9. Smith, M.L., Cavenagh, J.D., Lister, T.A. & Fitzgibbon, J. (2004) Mutation of CEBPA in familial acute myeloid leukemia. The New England Journal of Medicine, 351, 2403-2407.
10. Tong, Q., Tsai, J., Tan, G., Dalgin, G. & Hotamisligil, G.S. (2005) Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation. Molecular and Cellular Biology, 25, 706-715.
11. Wouters, B.J., Lowenberg, B., Erpelinck-Verschueren, C.A., van Putten, W.L., Valk, P.J. & Delwel, R. (2009) Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood, 113, 3088-3091.
12. Yan, X.J., Xu, J., Gu, Z.H., Pan, C.M., Lu, G., Shen, Y., Shi, J.Y., Zhu, Y.M., Tang, L., Zhang, X.W., Liang, W.X., Mi, J.Q., Song, H.D., Li, K.Q., Chen, Z. & Chen, S.J. (2011) Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics, 43, 309-315.